Merck & Cie Tells ITC Rivals Infringed Supplement Patents
A Swiss unit of Merck KGaA and others on Monday alleged in the U.S. International Trade Commission that Gnosis SpA and Macoven Pharmaceuticals Inc. are importing and selling products that infringe...To view the full article, register now.
Already a subscriber? Click here to view full article